PLRX
Pliant Therapeutics
$1.08
−$0.01 (−0.92%)Jul 27, 2026
Key metrics
The numbers that frame PLRX today
- Market cap
- $66.87M
- P/E (TTM)
- -0.6
- EV / FCF
- -0.7
- ROIC
- -51.6%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $1.05
- 52wk High
- $1.95
Growth
Revenue and earnings trend for PLRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PLRX
Is Pliant Therapeutics a good buy?
No. Pliant Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Pliant Therapeutics is selling at a very high price.
What is the market capitalization of PLRX?
Pliant Therapeutics's market capitalization is $66.87M.
What is the P/E ratio for PLRX stock?
Pliant Therapeutics's current P/E ratio is -0.6.
What is the 52-week high for PLRX stock?
The 52-week high for Pliant Therapeutics is $1.95. The current close of $1.08 is 44.6% below that high.
What is the 52-week low for PLRX stock?
The 52-week low for Pliant Therapeutics is $1.05. The current close of $1.08 is 2.9% above that low.
Does PLRX stock pay dividends?
Pliant Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PLRX?
Pliant Therapeutics's Debt / Equity ratio is 0.17.